Skip to main content
SpringerLink
Log in

Primary aldosteronism due to adrenal carcinomas

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In the present study two patients with aldosterone-producing adrenal carcinomas are reported. The clinical features were characterized by hypertension and severe hypokalemia with muscular weakness, flaccid paralysis of arms and legs, diarrhea and polyuria. In both cases excessively high plasma aldosterone levels and suppressed plasma renin activity were found. In contrast to most other cases with aldosterone-secreting tumours plasma cortisol, urinary free cortisol excretion, 17-hydroxy- and 17-ketosteroids were in the normal range. There was no clinical evidence of oversecretion of sex hormones. After adrenalectomy blood pressure and serum potassium normalized and the clinical symptoms disappeared. Plasma aldosterone and urinary aldosterone secretion returned to normal, while plasma renin activity remained low. Three and a half and 6 months later primary aldosteronism and the associated clinical symptoms reappeared due to hormonally active metastases. After introducing the antitumour drug o,p′-DDD in patient 1 aldosterone secretion normalized and the clinical status of the patient markedly improved. However, 10 months after diagnosis the patient died due to a haemorrhage from a liver metastasis. In patient 2 tumour-invaded regional lymph nodes were surgically removed with only minor changes in the hormone pattern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alterman SL, Dominguez C, Lopez-Gomez A, Lieber AL (1969) Primary adrenocortical carcinoma causing aldosteronism. Cancer 24:602

    Google Scholar 

  2. Andrade MA, Collet AB, Vieria OM, Luna RL, Andrade SV (1965) Carcinoma of the adrenal cortex with predominating mineralocorticoid effect. Rev Assoc Med Brasil 11:41

    Google Scholar 

  3. Bergenstal DM, Hertz R, Lipsett MB, Moy RH (1960) Chemotherapy of adrenocortical cancer with o,p′-DDD. Ann Intern Med 53:672

    Google Scholar 

  4. Brooks RV, McSwiney RR, Prunty FTG, Wood FJY (1957) Potassium deficiency of renal and adrenal origin. Am J Med 23:391

    Google Scholar 

  5. Brooks RV, Felix-Davies D, Radcliffe Lee M, Robertson PW (1972) Hyperaldosteronism from adrenal carcinoma. Br Med J 1:220

    Google Scholar 

  6. Brorson I (1964) Syndrome of mineralocorticoid excess illustrated by a case history of two tumours of the adrenal cortex in one patient. Acta Chir Scand 128:316–326

    Google Scholar 

  7. Brown RD, Strott CA (1971) Plasma deoxycorticosterone in man. J Clin Endocrinol 32:744–750

    Google Scholar 

  8. Cathelineau G, Poizat R (1976) Tumeur féminisante de la surrénale avec hyperaldostéronisme primaire et hypertension artérielle maligne. Ann Endocrinol 37:59

    Google Scholar 

  9. Conn JW (1955) Primary aldosteronism. II. A new clinical syndrome. J Lab Clin Med 45:6

    Google Scholar 

  10. Conn JW (1963) Aldosteronism in man. J Am Med Assoc 183:871

    Google Scholar 

  11. Crane MG, Harris JJ (1966) Desoxycorticosterone secretion rates in hyperadrenocorticism. J Clin Endocrinol 26:1135

    Google Scholar 

  12. Crane MG, Harris JJ, Herber R (1965) Primary aldosteronism due to an adrenal carcinoma. Ann Intern Med 63:494

    Google Scholar 

  13. De Asis DN, Samaan NA (1978) Feminizing adrenocrotical carcinoma with Cushing's syndrome and pseudohyperparathyroidism. Arch Intern Med 138:301

    Google Scholar 

  14. Ehrlich EN, Dominguez OV, Samuels LT, Lynch D, Oberhelman H, Warner NE (1963) Aldosteronism and precocious puberty due to an ovarian androblastoma (Sertoli cell tumor). J Clin Endocrinol 23:358

    Google Scholar 

  15. Ferris JB, Brown JJ, Fraser R (1975) Results of adrenal surgery in patients with hypertension, aldosterone excess and low plasma renin concentration. Br Med J 1:135

    Google Scholar 

  16. Filipecki S, Feltynowski T, Poplawska W, Lapinska K, Krus S, Wocial B, Januszewiz W (1972) Carcinoma of the adrenal cortex with hyperaldosteronism. J Clin Endocrinol Metab 35:225

    Google Scholar 

  17. Foye LV, Feichtmeir TV (1955) Adrenal cortical carcinoma producing solely mineralocorticoid effect. Am J Med 19:966

    Google Scholar 

  18. Gabrilove JL, Nicholis GL, Hansknecht RU, Wotiz HH (1970) Feminizing adrenocortical carcinoma in man. Cancer 24:153

    Google Scholar 

  19. Haber E, Koerner T, Page PB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J clin Endocrinol 29:1349

    Google Scholar 

  20. Huguenin A, Leborgne P, Ferrand B, Logeais Y, Almange C, Murie N, Louvet JP, Ramee MP, Pierres J (1975) Syndrome de Conn du a un cortico-surrénalome avec métastases. Rev Franç Endocrinol Clin 16:237

    Google Scholar 

  21. Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma: Clinical features of 138 patients. Am J Med 41:572

    Google Scholar 

  22. Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma: Results of treatment with o,p′-DDD in 138 patients. Am J Med 48:581

    Google Scholar 

  23. Kandrac MS, Zikanova ZD, Mach O (1957) Aldosterone and corticosteroids in a patient suffering from primary aldosteronism and carcinoma of the adrenal cortex. Sborn Lek 59 (9):283

    Google Scholar 

  24. Knapton PJ (1965) Hypokalemic alkalosis and adrenal carcinoma. Lancet II:346

    Google Scholar 

  25. Kumagai LF, West CD (1960) Steroid production in feminizing adrenocortical carcinoma and results of therapy with o,p′-DDD. Clin Res 8:110

    Google Scholar 

  26. Lubitz JA, Freeman L, Okun R (1973) Mitotane use in inoperable adrenal cortical carcinoma. J Am Med Assoc 223:1109

    Google Scholar 

  27. Luetscher JA (1958) The syndrome of mineralocorticoid excess. Ann Intern Med 48:1424

    Google Scholar 

  28. Marquezy RA, Bricaire H, Laudat MH, Courjaret J, Philbert M (1965) Adenocarcinoma of the adrenal with syndrome hyperandrogenia and hypermineralocorticism. Ann Endocrinol (Paris) 26:247

    Google Scholar 

  29. Mac Farlane DA (1958) Cancer of the adrenal cortex. Ann R Coll Surg Engl 23:155

    Google Scholar 

  30. Miyazaki G, Sasano N, Torkikai T, Fukuchi S (1973) Adrenocortical carcinoma with an isolated mineralocorticoid excess and recurrency fourteen years after removal of the tumor. Tohoku J Exp Med 109:365

    Google Scholar 

  31. Murphy BEP, Engelberg W, Pattee CJ (1963) Simple method for the determination of plasma corticoids. J Clin Endocrinol 23:293

    Google Scholar 

  32. Neville AM, Symington T (1966) Pathology of primary aldosteronism. Cancer 12:1854

    Google Scholar 

  33. Peterson RW, Wyngaarden JB, Guerra SL, Brodie BB, Bunim JJ (1955) The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest 34:1779

    Google Scholar 

  34. Peterson RW, Pierce CE (1960) Determination of urinary neutral 17-ketosteroids. In: Sunderman FW, Sunderman FW Jr (eds) Lipids and the Steroid Hormones in Clinical Medicine. Lippicot, Philadelphia

    Google Scholar 

  35. Rapaport E, Goldberg MB, Gordan GS, Amman F (1952) Mortality in surgically treated adrenocortical tumours. Postgrad Med 11:325

    Google Scholar 

  36. Revach M, Shilo S, Cabili S, Rubenstein Z, Selzer G (1977) Hyperaldosteronism caused by adrenal cortical carcinoma. Isr J Med Sci 13:1123

    Google Scholar 

  37. Salassa RM, Weeks RE, Northcutt RC, Carney JA (1974) Primary aldosteronism and malignant adrenocortical neoplasia. Trans Am Clin Assoc 86:163

    Google Scholar 

  38. Salvetti A, Pedrinelli R, Poli L, Giannesi D, Dalle Luche A, Duranti P (1977) The relationship of plasma and urinary aldosterone with sodium balance, plasma renin activity and age in normal subjects. J Nucl Med All Sci 21:7

    Google Scholar 

  39. Salvetti A, Pedrinelli R, Magagna A, Poli L, Sassano P, Arzilli F (1980) Influence of age and sodium intake on plasma renin activity of normal subjects. Nephron 26:189

    Google Scholar 

  40. Schambelan M, Slaton PE, Biglieri EG (1971) Mineralocorticoid production in hyperadrenocorticism. Am J Med 51:299–303

    Google Scholar 

  41. Santander RS, Gonzalez A, Suarez JA (1965) Case of probable mineralocorticoid excess without hypercortisolism due to a carcinoma of the adrenal cortex. J Clin Endocrinol 25:1429

    Google Scholar 

  42. Six R, Leclercq R, Noeninckx F (1972) Hyperaldocorticoidism: The sole clinical manifestation of an adrenal cortical carcinoma. Acta Clin Belg 27:426

    Google Scholar 

  43. Tenschert W, Vetter H, Siegenthaler W, Vetter W (1981) Diagnostik und Therapie bei hormonell aktiven Karzinomen der Nebennierenrinde. Schweiz Med Wochenschr 111:1080

    Google Scholar 

  44. Thorn GW, Lauler DP (1972) Clinical therapeutics of adrenal disorders. Am J Med 53:673

    Google Scholar 

  45. Todesco S, Terribile V, Borsatti A, Mantero F (1975) Primary aldosteronism due to a malignant ovarian tumour. J Clin Endocrinol Metab 41:809

    Google Scholar 

  46. Touitou Y, Bogdan A, Luton J-P (1978) Changes in corticosteroid synthesis of the human adrenal cortex in vitro induced by treatment with o,p′-DDD for Cushing's syndrome: Evidence for the sites of action of the drug. J Steroid Biochem 9:1217

    Google Scholar 

  47. Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography. I. Determination of urinary 18-glucuronide excretion. Acta Endocrinol 74:548

    Google Scholar 

  48. Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography. II. Determination of plasma aldosterone. Acta Endocrinol 74:558

    Google Scholar 

  49. Vetter H, Siebenschein R, Studer A, Wittassek F, Furrer J, Glänzer K, Siegenthaler W, Vetter W (1978) Primary aldosteronism: Inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone. Acta Endocrinol 89:710

    Google Scholar 

  50. Wallach S, Brown H, Englert E, Eik-Nes K (1957) Adrenocortical carcinoma with gynaecomastia: A case report and review of the literature. J Clin Endocrinol 17:945

    Google Scholar 

  51. West CD, Kumagai LF, Simons EL, Dominguez OV, Berliner DL (1964) Adrenocortical carcinoma with feminization and hypertension associated with a defect in 11 beta-hydroxylation. J Clin Endocrinol 24:567

    Google Scholar 

  52. Zimmermann B, Moran WH, Rosenberg JC, Kennedy BJ, Frey RJ (1959) Physiologic and surgical problems in the management of primary aldosteronism. Ann Surg 150:653

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department für Innere Medizin, Universitätsspital Zürich, Schweiz

    T. Lüscher, W. Tenscher & W. Vetter

  2. Department für Pathologie, Universitätsspital Zürich, Schweiz

    R. Maurer

  3. Medizinische Universitäts-Poliklinik, Münster

    H. Vetter

  4. First Medical Clinic, University of Pisa, Italy

    A. Salvetti, R. Pedrinelli, F. Turini & G. Maltinti

Authors
  1. T. Lüscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Tenscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Salvetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Pedrinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Turini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Maltinti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lüscher, T., Tenscher, W., Salvetti, A. et al. Primary aldosteronism due to adrenal carcinomas. Klin Wochenschr 62, 470–476 (1984). https://doi.org/10.1007/BF01726909

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01726909

Key words

Search

Navigation